Human GBP1 differentially targets <i>Salmonella</i> and <i>Toxoplasma</i> to license recognition of microbial ligands and caspase-mediated death

Daniel Fisch(Boston Children's Hospital), Eva‐Maria Frickel(University of Geneva)
bioRxiv (Cold Spring Harbor Laboratory)
October 5, 2019
Cited by 4


Related Papers